Intensive Combination Approach to Rollback the Epidemic in Nigerian Adolescents: UH3 Phase
NCT ID: NCT04950153
Last Updated: 2024-10-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
558 participants
INTERVENTIONAL
2021-04-15
2024-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Intensive Combination Approach to Rollback the HIV Epidemic in Nigerian Youth (iCARE) Plus Effectiveness/Implementation Hybrid Study
NCT06880224
Combination Intervention to Enhance Treatment Engagement and Viral Suppression Among Sexual and Gender Minority Youth in Nigeria
NCT06190613
Adolescent Coordinated Transition Nigerian HIV+ Youth
NCT03152006
PeerNaija: A Mobile Health Platform Incentivizing Medication Adherence Among Youth Living With HIV in Nigeria
NCT04930198
Support for Adolescents Living With HIV in South Africa
NCT06035445
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
HIV Testing Intervention
Combination HIV testing and linkage to care intervention includes social media engagement and peer navigation
Social Media Engagement
HIV testing outreach using social media platforms to promote HIV testing.
Testing Peer Navigation
Peer navigators will conduct HIV testing outreach and linkage to care to at-risk youth
HIV Treatment Intervention
Combination HIV treatment outcomes (retention, ART adherence and viral suppression) intervention includes SMS text messaging and peer navigation
Peer navigation
Peer navigators will navigate youth with HIV to provide assistance and support to optimize adherence to antiretroviral treatment (ART)
SMS Text messaging
Short Message System (SMS) text messages to remind and encourage youth to adhere to their ART
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Peer navigation
Peer navigators will navigate youth with HIV to provide assistance and support to optimize adherence to antiretroviral treatment (ART)
SMS Text messaging
Short Message System (SMS) text messages to remind and encourage youth to adhere to their ART
Social Media Engagement
HIV testing outreach using social media platforms to promote HIV testing.
Testing Peer Navigation
Peer navigators will conduct HIV testing outreach and linkage to care to at-risk youth
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Registered in the study clinics or their satellite clinics
* On antiretroviral therapy (ART) for at least 3 months
* Intention to remain a study clinic patient during the study observation and intervention period
Exclusion Criteria
* Youths who are 15 years old and not emancipated, who do not have parental consent
15 Years
24 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
NIH
Northwestern University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Babafemi Taiwo
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Babafemi Taiwo, MBBS
Role: PRINCIPAL_INVESTIGATOR
Northwestern University
Robert Garofalo, MD
Role: PRINCIPAL_INVESTIGATOR
Ann & Robert Lurie Childrens Hospital of Chicago
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Ibadan
Ibadan, , Nigeria
Jos University Teaching Hospital
Jos, , Nigeria
Lagos State University Teaching Hospital
Lagos, , Nigeria
Lagos University Teaching Hospital
Lagos, , Nigeria
Nigerian Institute of Medical Research (NIMR)
Lagos, , Nigeria
Olabisi Onabanjo University Teaching Hospital
Sagamu, , Nigeria
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Kozhumam A, Singh R, Agbaji O, Adetunji A, Taiwo B, Omigbodun O, Kuti K, David A, Akanmu S, Adekambi F, Akinbami A, Oladeji B, Taiwo B, Kuhns LM, Okonkwor O, Berzins B, Johnson AK, Badru T, Janulis P, Adewumi OM, Cervantes M, Awolude O, Garofalo R, Ahonkhai AA, Hirschhorn LR. Attitudes toward scale-up of an Intensive Combination Approach to Rollback the Epidemic in Nigerian adolescents (iCARE) intervention for youth in Nigeria: results of a mixed methods early-implementation study. Implement Sci Commun. 2025 Jan 8;6(1):6. doi: 10.1186/s43058-024-00671-z.
Taiwo BO, Kuhns LM, Omigbodun O, Awolude O, Kuti KM, Adetunji A, Berzins B, Janulis P, Akanmu S, Agbaji O, David AN, Akinbami A, Adekambi AF, Johnson AK, Okonkwor O, Oladeji BD, Cervantes M, Adewumi OM, Kapogiannis B, Garofalo R. A randomized stepped wedge trial of an intensive combination approach to roll back the HIV epidemic in Nigerian adolescents: iCARE Nigeria treatment support protocol. PLoS One. 2023 Jul 7;18(7):e0274031. doi: 10.1371/journal.pone.0274031. eCollection 2023.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
iCARE Nigeria UH3
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.